1. Home
  2. FOXF vs SLS Comparison

FOXF vs SLS Comparison

Compare FOXF & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fox Factory Holding Corp.

FOXF

Fox Factory Holding Corp.

HOLD

Current Price

$18.78

Market Cap

782.9M

ML Signal

HOLD

Logo SELLAS Life Sciences Group Inc.

SLS

SELLAS Life Sciences Group Inc.

BUY

Current Price

$8.06

Market Cap

924.5M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
FOXF
SLS
Founded
2007
2012
Country
United States
United States
Employees
3700
N/A
Industry
Motor Vehicles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
782.9M
924.5M
IPO Year
2013
2007

Fundamental Metrics

Financial Performance
Metric
FOXF
SLS
Price
$18.78
$8.06
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$30.25
$10.00
AVG Volume (30 Days)
469.2K
8.5M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.00
EPS
N/A
N/A
Revenue
$1,467,321,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.90
$110.98
P/E Ratio
N/A
N/A
Revenue Growth
5.27
N/A
52 Week Low
$13.08
$1.39
52 Week High
$31.18
$9.51

Technical Indicators

Market Signals
Indicator
FOXF
SLS
Relative Strength Index (RSI) 58.43 55.54
Support Level $18.03 $7.07
Resistance Level $19.09 $9.51
Average True Range (ATR) 0.70 0.66
MACD 0.05 -0.16
Stochastic Oscillator 84.09 45.84

Price Performance

Historical Comparison
FOXF
SLS

About FOXF Fox Factory Holding Corp.

Fox Factory Holding Corp is a designer, manufacturer, and marketer of performance-defining products and systems used predominantly on bikes, Side-by-Sides, on-road vehicles with and without off-road capabilities, off-road vehicles and trucks, ATVs, snowmobiles, specialty vehicles and applications, motorcycles, and commercial trucks. Its business operates under the FOX, FOX RACING SHOX, and RACE FACE brands. Geographically, it derives a majority of revenue from North America and also has a presence in Asia, Europe, and the Rest of the World. The company operates in three segments: Powered Vehicles Group, Aftermarket Applications Group, and Specialty Sports Group, of which it derives maximum revenue from Specialty Sports Group segment.

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Share on Social Networks: